Kentucky to Inject $42M into Psychedelic Research
The state of Kentucky joins the growing number of regions that are investing in psychedelics by injecting tens of millions of dollars into researching the therapeutic potential of hallucinogens in substance use disorders. More specifically, Kentucky is investing more than $40 million in psychedelic research as part of its efforts to curb the growing opioid addiction crisis. Kentucky Attorney General Daniel Cameron said in a recent Kentucky Opioid Abatement Advisory Commission (KYOAAC) news conference that the commission wanted to investigate novel treatments for people suffering from opioid use disorder. The commission was formed in 2022 to distribute more than $842…